Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 162

1.

Survival trends of metastatic small intestinal neuroendocrine tumor: a population-based analysis of SEER database.

Shah CP, Mramba LK, Bishnoi R, Unnikrishnan A, Duff JM, Chandana SR.

J Gastrointest Oncol. 2019 Oct;10(5):869-877. doi: 10.21037/jgo.2019.05.02.

2.

Cardiotoxicity due to targeted anticancer agents: a growing challenge.

Shah CP, Moreb JS.

Ther Adv Cardiovasc Dis. 2019 Jan-Dec;13:1753944719843435. doi: 10.1177/1753944719843435. Review.

3.

Design, synthesis and biological evaluation of Helicobacter pylori inosine 5'-monophosphate dehydrogenase (HpIMPDH) inhibitors. Further optimization of selectivity towards HpIMPDH over human IMPDH2.

Shah CP, Purushothaman G, Thiruvenkatam V, Kirubakaran S, Juvale K, Kharkar PS.

Bioorg Chem. 2019 Jun;87:753-764. doi: 10.1016/j.bioorg.2019.04.001. Epub 2019 Apr 4.

PMID:
30974298
4.

MULTILAYERED OPTIC DISK HEMORRHAGE IN ADULTS WITHOUT A POSTERIOR VITREOUS DETACHMENT.

Chen X, Tye A, Shah CP, Baumal CR.

Retin Cases Brief Rep. 2019 Mar 28. doi: 10.1097/ICB.0000000000000864. [Epub ahead of print]

PMID:
30932996
5.

Novel chalcone and flavone derivatives as selective and dual inhibitors of the transport proteins ABCB1 and ABCG2.

Silbermann K, Shah CP, Sahu NU, Juvale K, Stefan SM, Kharkar PS, Wiese M.

Eur J Med Chem. 2019 Feb 15;164:193-213. doi: 10.1016/j.ejmech.2018.12.019. Epub 2018 Dec 10.

PMID:
30594677
6.

The Impact of Prefilled Syringes on Endophthalmitis Following Intravitreal Injection of Ranibizumab.

Storey PP, Tauqeer Z, Yonekawa Y, Todorich B, Wolfe JD, Shah SP, Shah AR, Koto T, Abbey AM, Morizane Y, Sharma P, Wood EH, Morizane-Hosokawa M, Pendri P, Pancholy M, Harkey S, Jeng-Miller KW, Obeid A, Borkar DS, Chen E, Williams P, Okada AA, Inoue M, Shiraga F, Hirakata A, Shah CP, Prenner J, Garg S; Post-Injection Endophthalmitis (PIE) Study Group.

Am J Ophthalmol. 2019 Mar;199:200-208. doi: 10.1016/j.ajo.2018.11.023. Epub 2018 Dec 13.

PMID:
30552891
7.

Progression to Surgery for Patients With Idiopathic Epiretinal Membranes and Good Vision.

Chen X, Klein KA, Shah CP, Heier JS.

Ophthalmic Surg Lasers Imaging Retina. 2018 Oct 15;49(10):S18-S22. doi: 10.3928/23258160-20180814-03.

PMID:
30339263
8.

Discovery of novel human inosine 5'-monophosphate dehydrogenase 2 (hIMPDH2) inhibitors as potential anticancer agents.

Shah CP, Kharkar PS.

Eur J Med Chem. 2018 Oct 5;158:286-301. doi: 10.1016/j.ejmech.2018.09.016. Epub 2018 Sep 7.

PMID:
30223117
9.

Management of Floaters.

Shah CP, Fine HF.

Ophthalmic Surg Lasers Imaging Retina. 2018 Jun 1;49(6):388-391. doi: 10.3928/23258160-20180601-01. No abstract available.

PMID:
29927464
10.

Newer human inosine 5'-monophosphate dehydrogenase 2 (hIMPDH2) inhibitors as potential anticancer agents.

Shah CP, Kharkar PS.

J Enzyme Inhib Med Chem. 2018 Dec;33(1):972-977. doi: 10.1080/14756366.2018.1474211.

11.

Is Excess Alcohol Consumption an Unrecognized Factor Contributing to Falls?

Shah CP, Horner S, Sanders DS, Armstrong S, Sanders S.

Geriatr Orthop Surg Rehabil. 2018 Mar 29;9:2151459318760346. doi: 10.1177/2151459318760346. eCollection 2018. No abstract available.

12.

Methodological and Efficacy Issues in a Randomized Clinical Trial Investigating Vitreous Floater Treatment-Reply.

Shah CP, Heier JS.

JAMA Ophthalmol. 2018 Apr 1;136(4):449-450. doi: 10.1001/jamaophthalmol.2018.0218. No abstract available.

PMID:
29522152
13.

The best of the best: a review of select retina case reports published in 2015.

Dang S, Shah CP.

Digit J Ophthalmol. 2016 Dec 31;22(4):79-81. doi: 10.5693/djo.01.2016.06.002. eCollection 2016. Review.

14.

The Role of Pneumatic Retinopexy: Lessons Learned and Keys to Successful Outcomes.

Cohen MN, Fine HF, Shah CP.

Ophthalmic Surg Lasers Imaging Retina. 2017 Aug 1;48(8):611-615. doi: 10.3928/23258160-20170802-02. No abstract available.

PMID:
28810035
15.

YAG Laser Vitreolysis vs Sham YAG Vitreolysis for Symptomatic Vitreous Floaters: A Randomized Clinical Trial.

Shah CP, Heier JS.

JAMA Ophthalmol. 2017 Sep 1;135(9):918-923. doi: 10.1001/jamaophthalmol.2017.2388.

16.

Reply.

Anaya JA, Shah CP, Heier JS, Morley MG.

Ophthalmology. 2017 Mar;124(3):e28. doi: 10.1016/j.ophtha.2016.05.050. No abstract available.

PMID:
28219512
17.

Choroidal Effusions Secondary to Carotid Cavernous Fistula.

Sheng J, Lally DR, Shah CP.

Ophthalmol Retina. 2017 May - Jun;1(3):226. doi: 10.1016/j.oret.2016.11.009. Epub 2017 May 1. No abstract available.

PMID:
31047425
18.

Efficacy and safety of the intensive dose of rosuvastatin 40mg/day in patients with acute coronary syndrome and at high risk of cardiovascular disease-ROSUVEES-2.

Shah CP, Shah BP, Dani SI, Channa BB, Lakshmanan SS, Krishnamani NC, Mehta A, Moorthy P.

Indian Heart J. 2016 Nov - Dec;68(6):766-771. doi: 10.1016/j.ihj.2016.09.002. Epub 2016 Sep 21.

19.

Expanded spectral domain-OCT findings in the early detection of hydroxychloroquine retinopathy and changes following drug cessation.

Lally DR, Heier JS, Baumal C, Witkin AJ, Maler S, Shah CP, Reichel E, Waheed NK, Bussel I, Rogers A, Duker JS.

Int J Retina Vitreous. 2016 Jul 18;2:18. eCollection 2016.

20.

Vascular endothelial growth factor and diabetic macular edema.

Lally DR, Shah CP, Heier JS.

Surv Ophthalmol. 2016 Nov - Dec;61(6):759-768. doi: 10.1016/j.survophthal.2016.03.010. Epub 2016 Apr 1. Review.

PMID:
27045225
21.

MICROBIOLOGIC SPECTRUM AND VISUAL OUTCOMES OF ACUTE-ONSET ENDOPHTHALMITIS UNDERGOING THERAPEUTIC PARS PLANA VITRECTOMY.

Sridhar J, Yonekawa Y, Kuriyan AE, Joseph A, Thomas BJ, Liang MC, Rayess N, Relhan N, Wolfe JD, Shah CP, Witkin AJ, Flynn HW Jr, Garg SJ.

Retina. 2017 Jul;37(7):1246-1251. doi: 10.1097/IAE.0000000000001358.

22.

Aflibercept for Diabetic Macular Edema in Eyes Previously Treated With Ranibizumab and/or Bevacizumab May Further Improve Macular Thickness.

Shah CP, Heier JS.

Ophthalmic Surg Lasers Imaging Retina. 2016 Sep 1;47(9):836-9. doi: 10.3928/23258160-20160901-06.

PMID:
27631479
23.

Outcomes after Failed Pneumatic Retinopexy for Retinal Detachment.

Anaya JA, Shah CP, Heier JS, Morley MG.

Ophthalmology. 2016 May;123(5):1137-42. doi: 10.1016/j.ophtha.2016.01.017. Epub 2016 Mar 5.

PMID:
26952593
24.

Postinjection Endophthalmitis Rates and Characteristics Following Intravitreal Bevacizumab, Ranibizumab, and Aflibercept.

Rayess N, Rahimy E, Storey P, Shah CP, Wolfe JD, Chen E, DeCroos FC, Garg SJ, Hsu J.

Am J Ophthalmol. 2016 May;165:88-93. doi: 10.1016/j.ajo.2016.02.028. Epub 2016 Mar 2.

PMID:
26944277
25.

Incidence and clinical features of post-injection endophthalmitis according to diagnosis.

Rayess N, Rahimy E, Shah CP, Wolfe JD, Chen E, DeCroos FC, Storey P, Garg SJ, Hsu J.

Br J Ophthalmol. 2016 Aug;100(8):1058-61. doi: 10.1136/bjophthalmol-2015-307707. Epub 2015 Nov 19.

PMID:
26584579
26.

Chemotherapy for Malignant Intraocular Tumors.

Shah CP, Shields CL, Shields JA.

Dev Ophthalmol. 2016;55:337-43. doi: 10.1159/000438958. Epub 2015 Oct 26. Review.

PMID:
26501748
27.

Surgical Outcomes for Persistent Macular Hole After Ocriplasmin.

Lee GD, Taney LS, Rogers AH, Shah CP, Duker JS, Baumal CR.

Ophthalmic Surg Lasers Imaging Retina. 2015 Jul-Aug;46(7):732-6. doi: 10.3928/23258160-20150730-07.

PMID:
26247454
28.

Inosine 5'-monophosphate dehydrogenase inhibitors as antimicrobial agents: recent progress and future perspectives.

Shah CP, Kharkar PS.

Future Med Chem. 2015;7(11):1415-29. doi: 10.4155/fmc.15.72. Review.

PMID:
26230881
29.

Teaching NeuroImages: Cat-scratch optic neuropathy without neuroretinitis.

Vodopivec I, Shah CP, Prasad S, Cohen AB.

Neurology. 2015 Jun 16;84(24):e204-5. doi: 10.1212/WNL.0000000000001683. No abstract available.

PMID:
26078406
30.

Rapid grading of fundus photographs for diabetic retinopathy using crowdsourcing.

Brady CJ, Villanti AC, Pearson JL, Kirchner TR, Gupta OP, Shah CP.

J Med Internet Res. 2014 Oct 30;16(10):e233. doi: 10.2196/jmir.3807.

31.

Treatment of dystrophic calcification on a silicone intraocular lens with pars plana vitrectomy.

Mehta N, Goldberg RA, Shah CP.

Clin Ophthalmol. 2014 Jul 8;8:1291-3. doi: 10.2147/OPTH.S62108. eCollection 2014.

32.

Noninfectious inflammation after intravitreal injection of aflibercept: clinical characteristics and visual outcomes.

Goldberg RA, Shah CP, Wiegand TW, Heier JS.

Am J Ophthalmol. 2014 Oct;158(4):733-737.e1. doi: 10.1016/j.ajo.2014.06.019. Epub 2014 Jun 28.

PMID:
24983791
33.

Initial utilization of aflibercept in exudative age-related macular degeneration.

Cho H, Weber ML, Shah CP, Heier JS.

Eur J Ophthalmol. 2014 Jul-Aug;24(4):576-81. doi: 10.5301/ejo.5000421. Epub 2014 Mar 17.

PMID:
24706352
34.

Initial presentation of pseudoxanthoma elasticum.

Goldman DR, Lee GD, Shah CP, Heier JS.

JAMA Ophthalmol. 2013 Oct;131(10):1352. doi: 10.1001/jamaophthalmol.2013.4511. No abstract available.

PMID:
24114133
35.

Expanded criteria for pneumatic retinopexy and potential cost savings.

Goldman DR, Shah CP, Heier JS.

Ophthalmology. 2014 Jan;121(1):318-326. doi: 10.1016/j.ophtha.2013.06.037. Epub 2013 Aug 14.

PMID:
23953099
36.

Aflibercept for exudative AMD with persistent fluid on ranibizumab and/or bevacizumab.

Cho H, Shah CP, Weber M, Heier JS.

Br J Ophthalmol. 2013 Aug;97(8):1032-5. doi: 10.1136/bjophthalmol-2013-303344. Epub 2013 Jun 13.

PMID:
23766432
37.

Design, synthesis and antistaphylococcal activity of marine pyrrole alkaloid derivatives.

Rane RA, Sahu NU, Shah CP, Shah NK.

J Enzyme Inhib Med Chem. 2014 Jun;29(3):401-7. doi: 10.3109/14756366.2013.793183. Epub 2013 May 10.

PMID:
23663080
38.

Synthesis and evaluation of novel marine bromopyrrole alkaloid-based hybrids as anticancer agents.

Rane RA, Sahu NU, Gutte SD, Mahajan AA, Shah CP, Bangalore P.

Eur J Med Chem. 2013 May;63:793-9. doi: 10.1016/j.ejmech.2013.03.029. Epub 2013 Mar 26.

PMID:
23584542
39.

Electroretinographic effects of omega-3 Fatty Acid supplementation on dry age-related macular degeneration.

Gerstenblith AT, Baskin DE, Shah CP, Wolfe JD, Fineman MS, Kaiser RS, Ho AC.

JAMA Ophthalmol. 2013 Mar;131(3):365-9. doi: 10.1001/jamaophthalmol.2013.642.

PMID:
23494041
40.

Synthesis and antibiofilm activity of marine natural product-based 4-thiazolidinones derivatives.

Rane RA, Sahu NU, Shah CP.

Bioorg Med Chem Lett. 2012 Dec 1;22(23):7131-4. doi: 10.1016/j.bmcl.2012.09.073. Epub 2012 Oct 3.

PMID:
23084904
41.

Eyelid cutaneous hypopigmentation after sub-tenon triamcinolone injection after retinal detachment repair.

Shah CP, Rhee D, Garg SJ.

Retin Cases Brief Rep. 2012 Summer;6(3):271-2. doi: 10.1097/ICB.0b013e3182278843.

PMID:
25389730
42.

Severe loss and recovery of vision after glaucoma filtration surgery.

Chen BH, Gordon HB, Shah CP, Spaeth GL.

J Glaucoma. 2012 Mar;21(3):144-6. doi: 10.1097/IJG.0b013e31820e2cf4.

PMID:
22373594
43.

Increasing aboriginal cultural safety among health care practitioners.

Shah CP, Reeves A.

Can J Public Health. 2012 Nov 7;103(5):e397. No abstract available.

PMID:
23617997
44.

EUS-FNA for pancreatic neuroendocrine tumors: a tertiary cancer center experience.

Atiq M, Bhutani MS, Bektas M, Lee JE, Gong Y, Tamm EP, Shah CP, Ross WA, Yao J, Raju GS, Wang X, Lee JH.

Dig Dis Sci. 2012 Mar;57(3):791-800. doi: 10.1007/s10620-011-1912-7. Epub 2011 Oct 1.

PMID:
21964743
45.

Topical aqueous suppression does not significantly affect duration of intraocular gas tamponade after vitrectomy.

Shah CP, Hsu J, Spirn MJ, Donoso L, Garg SJ.

Retina. 2012 Jan;32(1):168-71. doi: 10.1097/IAE.0b013e31822092a4.

PMID:
21878847
46.

A comparative bacteriological profile and antibiogram of dacryocystitis.

Shah CP, Santani D.

Nepal J Ophthalmol. 2011 Jul-Dec;3(2):134-9. doi: http://dx.doi.org/10.3126/nepjoph.v3i2.5265.

PMID:
21876586
47.

Outcomes and risk factors associated with endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor agents.

Shah CP, Garg SJ, Vander JF, Brown GC, Kaiser RS, Haller JA; Post-Injection Endophthalmitis (PIE) Study Team.

Ophthalmology. 2011 Oct;118(10):2028-34. doi: 10.1016/j.ophtha.2011.02.034. Epub 2011 Jun 25.

PMID:
21705087
48.

Extrusion of hydrogel exoplant into upper eyelid 16 years after a scleral buckle procedure.

Shah CP, Garg SJ, Penne RB.

Indian J Ophthalmol. 2011 May-Jun;59(3):238-9. doi: 10.4103/0301-4738.81047.

49.

Dilution induced thickening in hydrotrope-rich rod-like micelles.

Verma G, Aswal VK, Fritz-Popovski G, Shah CP, Kumar M, Hassan PA.

J Colloid Interface Sci. 2011 Jul 1;359(1):163-70. doi: 10.1016/j.jcis.2011.03.061. Epub 2011 Mar 23.

PMID:
21507419
50.

Direct cyclopexy with a posterior infusion cannula.

Rabinowitz M, Khator P, Shah CP, Ichhpujani P, Spirn MJ, Moster MR.

Ophthalmic Surg Lasers Imaging. 2011 Mar-Apr;42(2):175-6. doi: 10.3928/15428877-20110316-03.

PMID:
21410110

Supplemental Content

Support Center